ViroGates A/S (CPH:VIRO)

Denmark flag Denmark · Delayed Price · Currency is DKK
15.45
-0.20 (-1.28%)
Dec 5, 2025, 3:50 PM CET
4.39%
Market Cap 143.41M
Revenue (ttm) 8.11M
Net Income (ttm) -12.39M
Shares Out 9.28M
EPS (ttm) -1.60
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,793
Average Volume 3,040
Open 15.55
Previous Close 15.65
Day's Range 15.45 - 15.55
52-Week Range 5.98 - 17.40
Beta 0.95
RSI 55.14
Earnings Date Nov 6, 2025

About ViroGates

ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector. It offers suPARnostic, a proprietary biomarker used in hospital clinics to guide and inform individuals of their health state, and in hospitals to support clinical decisions and identify high-risk patients, as well as used for a range of acute and chronic health issues, such as cardiovascular disease, type 2 diabetes, and cancer. The company’s product includes suPARnostic TurbiLatex, a latex particle-enhan... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2000
Employees 10
Stock Exchange Copenhagen Stock Exchange
Ticker Symbol VIRO
Full Company Profile

Financial Performance

In 2024, ViroGates's revenue was 7.14 million, an increase of 2.22% compared to the previous year's 6.99 million. Losses were -14.35 million, 18.6% more than in 2023.

Financial Statements

News

There is no news available yet.